Search results
FDA Approves Lecanemab, a New Alzheimer’s Drug
Time via Yahoo News· 1 year agoCredit - Eisai Inc On Jan. 6, the U.S. Food and Drug Administration (FDA) approved a new drug to treat Alzheimer’s disease in its early stages....
FDA approves new Alzheimer’s drug that moderately slows disease
The Hill via AOL· 1 year agoAn experimental Alzheimer’s drug that moderately slows cognitive decline was approved by the Food...
The FDA just approved a new Alzheimer's drug that's set to be a blockbuster
Business Insider via Yahoo News· 1 year agoGetty Images The FDA just approved a new treatment for Alzheimer's disease from Eisai and Biogen. In...
FDA approves new Alzheimer’s drug that appears to slow progression of disease
The Today Show via AOL· 1 year agoThe Food and Drug Administration on Friday approved an Alzheimer’s drug shown in clinical trials to...
FDA Approves Alzheimer's Drug That Promises to Slow Cognitive Decline Early in the Disease
People via Yahoo News· 1 year agoAlzheimer’s drug Leqembi was approved Friday after clinical trial results found it slowed decline in...
US FDA grants standard approval of Eisai/Biogen Alzheimer's drug
Reuters via AOL· 10 months agoLOS ANGELES (Reuters) -Eisai and Biogen's Leqembi won a coveted standard approval nod from the U.S....
FDA Approves New Alzheimer's Drug, but There Are Lingering Questions
Gizmodo via Yahoo News· 1 year agoThe Food and Drug Administration on Friday granted the conditional approval of a new treatment for...
Explainer-Who is eligible for the new FDA-approved Alzheimer's drug?
Reuters via Yahoo News· 10 months agoThe U.S. Food and Drug Administration on Thursday granted standard approval to Eisai and Biogen's...
Eisai, Biogen get U.S. FDA approval for Alzheimer's drug, apply for full approval
Reuters via Yahoo Finance· 1 year ago(Reuters) -The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug lecanemab...
Biogen Skids As Analysts Debate Uptake For Newly Approved Alzheimer's Drug
Investor's Business Daily· 10 months agoBiogen stock skidded Friday after the Food and Drug Administration fully approved its Alzheimer's...